ArticleCardiovascular diabetology2024

Empagliflozin's role in reducing ventricular repolarization heterogeneity: insights into cardiovascular mortality decline from the EMPATHY-HEART trial.

Cristiane Lauretti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.